论文部分内容阅读
目的比较凝血酶雾化吸入和阿托品对支气管扩张咯血的疗效。方法 80例支气管扩张咯血患者随机分成2组,平均每组40人。第一组给予凝血酶雾化吸入进行治疗,第二组给予阿托品进行治疗。观察两药的疗效。观察期共1年。结果凝血酶雾化吸入和阿托品对支气管扩张咯血的疗效相比,凝血酶雾化吸入优于阿托品,差异具有统计学意义(χ2=3.82,P<0.05)。结论在我们的临床工作中,通过使用凝血酶雾化吸入对支气管扩张咯血进行治疗,能够更加有利于支气管扩张咯血患者的康复,起到良好的效果。
Objective To compare the efficacy of thrombin inhalation and atropine on bronchiectasis and hemoptysis. Methods Eighty patients with bronchiectasis and hemoptysis were randomly divided into two groups with an average of 40 in each group. The first group was given thrombin inhalation for treatment, and the second group was given atropine for treatment. Observe the efficacy of two drugs. Observation period a total of 1 year. Results Thrombin inhalation and atropine bronchodilator hemoptysis compared to the efficacy of thrombin inhalation is better than atropine, the difference was statistically significant (χ2 = 3.82, P <0.05). Conclusions In our clinical work, the treatment of bronchiectasis hemoptysis by inhalation with thrombin can be more beneficial to the rehabilitation of patients with bronchiectasis and hemoptysis and has good effect.